<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Gregory Glass | Site-Wide Activity</title>
	<link>https://fdapetitions.com/activity/</link>
	<atom:link href="https://fdapetitions.com/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for the entire site.</description>
	<lastBuildDate>Thu, 19 Mar 2026 12:59:42 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">4264b93978ed69c282793f8ce313c1a2</guid>
				<title>gregoryglass started the topic Fludarabine Phosphate Injection in the forum Safety Petitions</title>
				<link>https://fdapetitions.com/forums/topic/fludarabine-phosphate-injection/</link>
				<pubDate>Thu, 14 Dec 2023 15:40:07 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Fludarabine Phosphate Injection </b><br />
<b>Company: </b> Sandoz<br />
<b>Petition Filer: </b> Hisun<br />
<b>Petition Number(s): </b> 2023P-5450<br />
<b>Date of Petition: </b> December 13, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Action Requested by Petitioner: </b> The petitioner would like to FDA to determine whether Fludarabine Phosphate Injection (NDA 022137) was removed from the market for&hellip;<span class="activity-read-more" id="activity-read-more-1555"><a href="https://fdapetitions.com/forums/topic/fludarabine-phosphate-injection/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">5f241573ae212a6d0b4d49003d62ea98</guid>
				<title>gregoryglass started the topic Atropine Sulfate Injection in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/atropine-sulfate-injection-2/</link>
				<pubDate>Thu, 14 Dec 2023 13:41:01 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Atropine Sulfate Injection  </b><br />
<b>Company: </b> Fresenius Kabi<br />
<b>Petition Filer: </b> Biotech Research Group<br />
<b>Petition Number(s): </b> 2023P-5409<br />
<b>Date of First Petition: </b><br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a 4.0 mg/mL injection of atropine sulfate. It uses the Fresenius Kabi NDA&hellip;<span class="activity-read-more" id="activity-read-more-1554"><a href="https://fdapetitions.com/forums/topic/atropine-sulfate-injection-2/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">567277290454ae1779e9cf337a5e1750</guid>
				<title>gregoryglass started the topic Zoryve®(roflumislast) Cream in the forum Product Petitions</title>
				<link>https://fdapetitions.com/forums/topic/zoryveroflumislast-cream/</link>
				<pubDate>Fri, 08 Dec 2023 22:08:12 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Zoryve®(roflumislast) Cream </b><br />
<b>Company: </b> Acutis<br />
<b>Petition Filer: </b> Acutis<br />
<b>Petition Number(s): </b> 2023P-5364<br />
<b>Date of Petition: </b> December 6, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Issue and Implication:</b> Whether standard bioequivalence test is sufficient to ensure sameness.</p>
<p><b>Action Requested by Petitioner: </b> Petitioner is asking FDA to approve&hellip;<span class="activity-read-more" id="activity-read-more-1553"><a href="https://fdapetitions.com/forums/topic/zoryveroflumislast-cream/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">6c328de46dbf11e0cca6d63ddf271568</guid>
				<title>gregoryglass started the topic Xipere®(triamcinolone) Injection in the forum Product Petitions</title>
				<link>https://fdapetitions.com/forums/topic/xiperetriamcinolone-injection/</link>
				<pubDate>Fri, 08 Dec 2023 21:51:52 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Xipere®(triamcinolone) Injection  </b><br />
<b>Company: </b> Bausch Lomb<br />
<b>Petition Filer: </b> Bausch Lomb<br />
<b>Petition Number(s): </b> 2023P-5343<br />
<b>Date of Petition: </b> December 5, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Issue and Implication:</b> Whether an ANDA must have the same injection device to be approved.</p>
<p><b>Action Requested by Petitioner: </b> The Petitioner is asking&hellip;<span class="activity-read-more" id="activity-read-more-1552"><a href="https://fdapetitions.com/forums/topic/xiperetriamcinolone-injection/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">a09eb816c6a65364206064673a55e82a</guid>
				<title>gregoryglass started the topic Halaven®(eribulin) Injection in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/halaveneribulin-injection/</link>
				<pubDate>Wed, 29 Nov 2023 16:24:59 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Halaven®(eribulin) Injection  </b><br />
<b>Company: </b> Eisai<br />
<b>Petition Filer: </b> Hymen Phelps, a law firm<br />
<b>Petition Number(s): </b> 2023P-5135<br />
<b>Date of First Petition: </b> November 20, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a 2mg/4mL and 2.5mg/5mL vials of Halaven®(eribulin) Injection. U&hellip;<span class="activity-read-more" id="activity-read-more-1551"><a href="https://fdapetitions.com/forums/topic/halaveneribulin-injection/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">dfb9b7506d010008bc3d9f814c629c11</guid>
				<title>gregoryglass started the topic Vistaril®(hydroxyzine) Oral Solution in the forum Safety Petitions</title>
				<link>https://fdapetitions.com/forums/topic/vistarilhydroxyzine-oral-solution/</link>
				<pubDate>Wed, 29 Nov 2023 15:47:48 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Vistaril®(hydroxyzine) Oral Solution </b><br />
<b>Company: </b> Pfizer<br />
<b>Petition Filer: </b> Hymen Phelps, a law firm<br />
<b>Petition Number(s): </b> 2023P-5095<br />
<b>Date of Petition: </b> November 17, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Action Requested by Petitioner: </b> The petitioner would like to FDA to determine whether Vistaril®(hydroxyzine) Oral Solution 25mg/5mL (NDA 0&hellip;<span class="activity-read-more" id="activity-read-more-1550"><a href="https://fdapetitions.com/forums/topic/vistarilhydroxyzine-oral-solution/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">b1fb5c20196460202a531e1f806d38cc</guid>
				<title>gregoryglass started the topic Filsuvez® in the forum Product Petitions Archives</title>
				<link>https://fdapetitions.com/forums/topic/filsuvez/</link>
				<pubDate>Wed, 08 Nov 2023 12:49:28 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Filsuvez®  </b><br />
<b>Company: </b> Amryt Pharma<br />
<b>Petition Filer: </b> Lassman Law and Policy<br />
<b>Petition Number(s): </b> 2023P-4918<br />
<b>Date of Petition: </b> November 6, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Issue and Implication:</b> Whether FDA can approve a product that does not demonstrate efficacy.</p>
<p><b>Action Requested by Petitioner: </b> Petitioner is asking FDA to deny&hellip;<span class="activity-read-more" id="activity-read-more-1549"><a href="https://fdapetitions.com/forums/topic/filsuvez/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">900d553589bfb10580df3111a2650c19</guid>
				<title>gregoryglass started the topic Vigabatrin Oral Solution in the forum Product Petitions</title>
				<link>https://fdapetitions.com/forums/topic/vigabatrin-oral-solution/</link>
				<pubDate>Wed, 08 Nov 2023 12:35:58 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Vigabatrin Oral Solution  </b><br />
<b>Company: </b> Various<br />
<b>Petition Filer: </b> Sidley Austin, a law firm<br />
<b>Petition Number(s): </b> 2023P-4896<br />
<b>Date of Petition: </b> November 6, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Issue and Implication:</b> Whether FDA can grant a product Orphan Drug Exclusivity status when prior products have been designated as such.</p>
<p><b>Action&hellip;</b><span class="activity-read-more" id="activity-read-more-1548"><a href="https://fdapetitions.com/forums/topic/vigabatrin-oral-solution/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">1f1064c2a005e8862f02a1fdf6823d16</guid>
				<title>gregoryglass started the topic Lodin®(etodolac) Tablets in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/lodinetodolac-tablets/</link>
				<pubDate>Sat, 04 Nov 2023 19:44:10 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Lodin®(etodolac) Tablets  </b><br />
<b>Company: </b> Wyeth<br />
<b>Petition Filer: </b> Pharmobedient<br />
<b>Petition Number(s): </b> 2023P-4877<br />
<b>Date of First Petition: </b> November 3, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a 200 mg and 250 mg tablet of Lodin®(etodolac). It uses RLD (NDA #N018922) as t&hellip;<span class="activity-read-more" id="activity-read-more-1547"><a href="https://fdapetitions.com/forums/topic/lodinetodolac-tablets/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">a73911d72825db566f838bee4c3fc3e0</guid>
				<title>gregoryglass started the topic Imitrex®(sumatriptan) Oral Solution in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/imitrexsumatriptan-oral-solution/</link>
				<pubDate>Tue, 31 Oct 2023 13:48:44 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Imitrex®(sumatriptan) Oral Solution  </b><br />
<b>Company: </b> GlaxosmithKline<br />
<b>Petition Filer: </b> Hymen Phelps, a law firm<br />
<b>Petition Number(s): </b> 2023P-4784<br />
<b>Date of First Petition: </b> October 30, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for am oral solution form of Imitrex®(sumatriptan) O&hellip;<span class="activity-read-more" id="activity-read-more-1546"><a href="https://fdapetitions.com/forums/topic/imitrexsumatriptan-oral-solution/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">c737db4ac4d21045e7623b93d335edc0</guid>
				<title>gregoryglass started the topic Zipsor®(diclofenac) Capsules and OS in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/zipsordiclofenac-capsules/</link>
				<pubDate>Tue, 24 Oct 2023 15:53:11 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Zipsor®(diclofenac) Capsules  </b><br />
<b>Company: </b> Assertio<br />
<b>Petition Filer: </b> Hymen Phelps, a law firm<br />
<b>Petition Number(s): </b> 2023P-4659<br />
<b>Date of First Petition: </b> October 23, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a Zipsor®(diclofenac) Capsules 12.5mg. The RLD is the 25mg s&hellip;<span class="activity-read-more" id="activity-read-more-1545"><a href="https://fdapetitions.com/forums/topic/zipsordiclofenac-capsules/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">78b43e5a1d56b71a3ee5db6590f92e56</guid>
				<title>gregoryglass started the topic Neurontin®(gabapentin) Capsules and Tablets in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/neurontingabapentin-capsules/</link>
				<pubDate>Tue, 24 Oct 2023 15:44:03 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Neurontin®(gabapentin) Capsules  </b><br />
<b>Company: </b> Viatris<br />
<b>Petition Filer: </b> Hymen Phelps, a law firm<br />
<b>Petition Number(s): </b> 2023P-4568<br />
<b>Date of First Petition: </b> October 23, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a Neurontin®(gabapentin) Capsules in a variety of new dosage s&hellip;<span class="activity-read-more" id="activity-read-more-1544"><a href="https://fdapetitions.com/forums/topic/neurontingabapentin-capsules/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">98b8005a9de70c1b8150726d4c9b4f2b</guid>
				<title>gregoryglass started the topic Isuprel®(isptroterenol) Injection in the forum Safety Petitions</title>
				<link>https://fdapetitions.com/forums/topic/isuprelisptroterenol-injection/</link>
				<pubDate>Sat, 21 Oct 2023 14:41:18 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Isuprel®(isptroterenol) Injection </b><br />
<b>Company: </b> Bausch Health<br />
<b>Petition Filer: </b> 2023P-4636<br />
<b>Petition Number(s): </b> E. Rust Consulting<br />
<b>Date of Petition: </b> October 20, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Action Requested by Petitioner: </b> The petitioner would like to FDA to determine whether Isuprel®(isptroterenol) Injection (NDA 010515) was r&hellip;<span class="activity-read-more" id="activity-read-more-1543"><a href="https://fdapetitions.com/forums/topic/isuprelisptroterenol-injection/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">053422da5d29213ba4d3f250caee76a7</guid>
				<title>gregoryglass started the topic Sitagliptin Tablets in the forum Product Petitions</title>
				<link>https://fdapetitions.com/forums/topic/sitagliptin-tablets/</link>
				<pubDate>Sat, 21 Oct 2023 14:31:46 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Sitagliptin Tablets</b><br />
<b>Company: </b> Merck<br />
<b>Petition Filer: </b> Zydus<br />
<b>Petition Number(s): </b> 2023P-4616<br />
<b>Date of Petition: </b> October 20, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Issue and Implication:</b> Whether FDA should retract temporary guidance. </p>
<p><b>Action Requested by Petitioner: </b> Petitioner asks FDA to remove all sitagliptin products that contain more&hellip;<span class="activity-read-more" id="activity-read-more-1542"><a href="https://fdapetitions.com/forums/topic/sitagliptin-tablets/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">c6c23ee88ce5b1ab2cee7512ec224a8a</guid>
				<title>gregoryglass started the topic Trandate®(labetalol) Injection in the forum Suitability Petitions Archives</title>
				<link>https://fdapetitions.com/forums/topic/trandatelabetalol-injection/</link>
				<pubDate>Thu, 19 Oct 2023 13:53:20 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Trandate®(labetalol) Injection  </b><br />
<b>Company: </b> Sevela Ireland<br />
<b>Petition Filer: </b> None S Consulting<br />
<b>Petition Number(s): </b> 2023P-4552<br />
<b>Date of First Petition: </b> October 17, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a Trandate®(labetalol) Injection 20mg/4 mL (5mg/mL) Prefilled S&hellip;<span class="activity-read-more" id="activity-read-more-1541"><a href="https://fdapetitions.com/forums/topic/trandatelabetalol-injection/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">2200c9994d834fc82afef2a7aa80f9ba</guid>
				<title>gregoryglass started the topic Atropine Sulfate Ophthalmic Ointment in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/atropine-sulfate-ophthalmic-ointment/</link>
				<pubDate>Thu, 19 Oct 2023 12:22:07 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Atropine Sulfate Ophthalmic Ointment</b><br />
<b>Company: </b> Akorn<br />
<b>Petition Filer: </b> Pharmobedient<br />
<b>Petition Number(s): </b> 2023P-4550<br />
<b>Date of First Petition: </b> October 17, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a Atropine Sulfate Ophthalmic Ointment 1% using the ANDA (NDA 206289) as&hellip;<span class="activity-read-more" id="activity-read-more-1540"><a href="https://fdapetitions.com/forums/topic/atropine-sulfate-ophthalmic-ointment/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">373b26251a3420fdcb0f0e752c68f202</guid>
				<title>gregoryglass started the topic Mephyton®(phytonadione) Tablets in the forum Safety Petitions Archives</title>
				<link>https://fdapetitions.com/forums/topic/mephytonphytonadione-tablets/</link>
				<pubDate>Thu, 19 Oct 2023 12:08:26 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Mephyton®(phytonadione) Tablets </b><br />
<b>Company: </b> Bausch Health<br />
<b>Petition Filer: </b> Lachman Consultants<br />
<b>Petition Number(s): </b> 2023P-4596<br />
<b>Date of Petition: </b> October 18, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Action Requested by Petitioner: </b> The petitioner would like to FDA to determine whether  Mephyton®(phytonadione) Tablets (NDA 010104) was r&hellip;<span class="activity-read-more" id="activity-read-more-1539"><a href="https://fdapetitions.com/forums/topic/mephytonphytonadione-tablets/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">c15bddf167933e5575ab95624f7d64a0</guid>
				<title>gregoryglass started the topic Kemstro®(baclofen) Orally Disintegrating Tablets in the forum Safety Petitions</title>
				<link>https://fdapetitions.com/forums/topic/kemstrobaclofen-orally-disintegrating-tablets/</link>
				<pubDate>Thu, 19 Oct 2023 12:03:55 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Kemstro®(baclofen) Orally Disintegrating Tablets</b><br />
<b>Company: </b> UCB<br />
<b>Petition Filer: </b> Pharmobedient<br />
<b>Petition Number(s): </b> 2023P-4587<br />
<b>Date of Petition: </b> October 18, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Action Requested by Petitioner: </b> The petitioner would like to FDA to determine whether Kemstro®(baclofen) Orally Disintegrating Tablets (NDA 0&hellip;<span class="activity-read-more" id="activity-read-more-1538"><a href="https://fdapetitions.com/forums/topic/kemstrobaclofen-orally-disintegrating-tablets/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">31b2f94e933e2f8fde1c9a2eee4ee3ef</guid>
				<title>gregoryglass started the topic Ycanth®(cantharidin) Topical Solution in the forum Product Petitions</title>
				<link>https://fdapetitions.com/forums/topic/ycanthcantharidin-topical-solution/</link>
				<pubDate>Sat, 14 Oct 2023 13:15:49 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Ycanth®(cantharidin) Topical Solution  </b><br />
<b>Company: </b> Verrica Pharmaceuticals<br />
<b>Petition Filer: </b> Verrica Pharmaceuticals<br />
<b>Petition Number(s): </b> 2023P-4510<br />
<b>Date of Petition: </b> October 12, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Issue and Implication:</b> Whether FDA should remove Active Pharmaceutical Ingredients from the bulk and compounding list when&hellip;<span class="activity-read-more" id="activity-read-more-1537"><a href="https://fdapetitions.com/forums/topic/ycanthcantharidin-topical-solution/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">927f596b47ad4632695b85552803a645</guid>
				<title>gregoryglass started the topic Zinc Sulfate Injection in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/zinc-sulfate-injection/</link>
				<pubDate>Sat, 14 Oct 2023 13:02:48 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Zinc Sulfate Injection </b><br />
<b>Company: </b> American Regent<br />
<b>Petition Filer: </b> Gland Pharma<br />
<b>Petition Number(s): </b> 2023P-4463<br />
<b>Date of First Petition: </b><br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for two additional dosage strengths (or presentations) of Zinc Sulfate Injection. It uses the&hellip;<span class="activity-read-more" id="activity-read-more-1536"><a href="https://fdapetitions.com/forums/topic/zinc-sulfate-injection/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">69a3eea612034ae3e241721f7d028b4b</guid>
				<title>gregoryglass started the topic Selenious Acid Injection in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/selenious-acid-injection/</link>
				<pubDate>Thu, 12 Oct 2023 14:34:14 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Selenious Acid Injection  </b><br />
<b>Company: </b> American Regent<br />
<b>Petition Filer: </b> Pharmobedient<br />
<b>Petition Number(s): </b> 2023P-4465<br />
<b>Date of First Petition: </b> October 11, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a selenious acid injection using the RLD (N209379). It is not clear as&hellip;<span class="activity-read-more" id="activity-read-more-1535"><a href="https://fdapetitions.com/forums/topic/selenious-acid-injection/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">0e0a85b23f663a60a86222c0a6c0b56b</guid>
				<title>gregoryglass started the topic Glucotrol®(glipizide) Tablets in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/glucotrolglipizide-tablets-2/</link>
				<pubDate>Thu, 12 Oct 2023 13:55:38 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Glucotrol®(glipizide) Tablets  </b><br />
<b>Company: </b> Pfizer<br />
<b>Petition Filer: </b> Hymen Phelps, a law firm<br />
<b>Petition Number(s): </b> 2023P-4443<br />
<b>Date of First Petition: </b> October 11, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a scored 15mg tablet of glipizide. Using Glucotrol®(glipizide) T&hellip;<span class="activity-read-more" id="activity-read-more-1534"><a href="https://fdapetitions.com/forums/topic/glucotrolglipizide-tablets-2/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">a5fd466154fe71d81f91731c65ef942c</guid>
				<title>gregoryglass started the topic Desyrel®(trazodone) Tablets in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/desyreltrazodone-tablets/</link>
				<pubDate>Wed, 11 Oct 2023 11:26:59 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Desyrel®(trazodone) Tablets  </b><br />
<b>Company: </b> Pragma<br />
<b>Petition Filer: </b> Drug Device Consulting<br />
<b>Petition Number(s): </b> 2023P-4394<br />
<b>Date of First Petition: </b> October 10, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a Desyrel®(trazodone) Tablets 25 and 75mg. It uses the D&hellip;<span class="activity-read-more" id="activity-read-more-1533"><a href="https://fdapetitions.com/forums/topic/desyreltrazodone-tablets/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">01555bc3e15a8161964bab1b921cb9f9</guid>
				<title>gregoryglass started the topic Bromday®(bromfenac) Solution in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/bromdaybromfenac-solution/</link>
				<pubDate>Fri, 06 Oct 2023 15:14:50 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Bromday®(bromfenac) Solution  </b><br />
<b>Company: </b> Bausch and Lomb and Alembic<br />
<b>Petition Filer: </b> Pharmobedient<br />
<b>Petition Number(s): </b> 2023P-4359<br />
<b>Date of First Petition: </b> October 5, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a 0.08% strength of bromfenac solution/drops. It uses&hellip;<span class="activity-read-more" id="activity-read-more-1532"><a href="https://fdapetitions.com/forums/topic/bromdaybromfenac-solution/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">bf7bb403e0ad404e6f3f2ebbc06c2d9a</guid>
				<title>gregoryglass started the topic Sterile Water for Irrigation in the forum Suitability Petitions Archives</title>
				<link>https://fdapetitions.com/forums/topic/sterile-water-for-irrigation/</link>
				<pubDate>Wed, 04 Oct 2023 16:18:17 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Sterile Water for Irrigation  </b><br />
<b>Company: </b> B. Braun Medical<br />
<b>Petition Filer: </b> Fresenius Kabi<br />
<b>Petition Number(s): </b> 2023P-4331<br />
<b>Date of First Petition: </b> October 3, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for Sterile Water for Irrigation in 250mL and 1500mL fill sizes. It&hellip;<span class="activity-read-more" id="activity-read-more-1531"><a href="https://fdapetitions.com/forums/topic/sterile-water-for-irrigation/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">3aa7785cab2af356c5bdd50677c5e1fc</guid>
				<title>gregoryglass started the topic Dexchlorpheniramine Sachets in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/dexchlorpheniramine-sachets/</link>
				<pubDate>Wed, 04 Oct 2023 16:09:57 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Dexchlorpheniramine Sachets  </b><br />
<b>Company: </b> PAI Holdings and Capellon<br />
<b>Petition Filer: </b> Pharmobedient<br />
<b>Petition Number(s): </b> 2023P-4327<br />
<b>Date of First Petition: </b> October 3, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a Dexchlorpheniramine Powder for Solution, 2mg/Sachet. It&hellip;<span class="activity-read-more" id="activity-read-more-1530"><a href="https://fdapetitions.com/forums/topic/dexchlorpheniramine-sachets/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">4e1d64bbbcd917bebda7c1d701a3fed1</guid>
				<title>gregoryglass started the topic Sodium Chloride Irrigation in the forum Suitability Petitions Archives</title>
				<link>https://fdapetitions.com/forums/topic/sodium-chloride-irrigation/</link>
				<pubDate>Wed, 04 Oct 2023 16:00:09 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Sodium Chloride Irrigation  </b><br />
<b>Company: </b> B. Braun Medical<br />
<b>Petition Filer: </b> Fresenius Kabi<br />
<b>Petition Number(s): </b> 2023P-4324<br />
<b>Date of First Petition: </b> October 3, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a Sodium Chloride Irrigation 0.9% 250mL and 1500mL fill sizes in&hellip;<span class="activity-read-more" id="activity-read-more-1529"><a href="https://fdapetitions.com/forums/topic/sodium-chloride-irrigation/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">03bf6bcd651aff6e5c3136e8285c4927</guid>
				<title>gregoryglass started the topic Inderal®(propranolol) Orally Disintegrating Tablets in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/inderalpropranolol-orally-disintegrating-tablets/</link>
				<pubDate>Wed, 04 Oct 2023 13:45:53 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Inderal®(propranolol) Orally Disintegrating Tablets  </b><br />
<b>Company: </b> Wyeth<br />
<b>Petition Filer: </b> Lachman Consultants<br />
<b>Petition Number(s): </b> 2023P-4320<br />
<b>Date of First Petition: </b> October 3, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for Inderal®(propranolol) Orally Disintegrating T&hellip;<span class="activity-read-more" id="activity-read-more-1528"><a href="https://fdapetitions.com/forums/topic/inderalpropranolol-orally-disintegrating-tablets/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">17abc71542ab42895c18316ccdca1214</guid>
				<title>gregoryglass started the topic Lymphazurin®(isosulfan blue) Injection in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/lymphazurinisosulfan-blue-injection/</link>
				<pubDate>Wed, 04 Oct 2023 13:41:36 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Lymphazurin®(isosulfan blue) Injection  </b><br />
<b>Company: </b> Covidien<br />
<b>Petition Filer: </b> Lachman Consultants<br />
<b>Petition Number(s): </b> 2023P-4297<br />
<b>Date of First Petition: </b> October 3, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a 1%, 1mL prefilled syringe of Lymphazurin®(isosulfan b&hellip;<span class="activity-read-more" id="activity-read-more-1527"><a href="https://fdapetitions.com/forums/topic/lymphazurinisosulfan-blue-injection/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">f21961878b5741b447907b0253a45736</guid>
				<title>gregoryglass started the topic Tavist®(clemastine) Sachet and Orally Disintegrating Tablets in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/tavistclemastine-sachet/</link>
				<pubDate>Wed, 04 Oct 2023 13:31:55 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Tavist®(clemastine) Sachet  </b><br />
<b>Company: </b> Novartis<br />
<b>Petition Filer: </b> Pharmobedient<br />
<b>Petition Number(s): </b> 2023P-4292<br />
<b>Date of First Petition: </b> October 3, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a 1mg and 2mg sachet form of Tavist®(clemastine) Powder (NDA 018675) which r&hellip;<span class="activity-read-more" id="activity-read-more-1526"><a href="https://fdapetitions.com/forums/topic/tavistclemastine-sachet/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">5d7fc73a012e14db394dd29f5009eea3</guid>
				<title>gregoryglass started the topic Daypro®(oxaprozin) Tablets in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/dayprooxaprozin-tablets/</link>
				<pubDate>Wed, 04 Oct 2023 13:26:29 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Daypro®(oxaprozin) Tablets  </b><br />
<b>Company: </b> Pfizer<br />
<b>Petition Filer: </b> Pharmobedient<br />
<b>Petition Number(s): </b> 2023P-4290<br />
<b>Date of First Petition: </b> October 3, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a 300mg and 1200mg strength of Daypro®(oxaprozin) Tablets (NDA 018841). Using t&hellip;<span class="activity-read-more" id="activity-read-more-1525"><a href="https://fdapetitions.com/forums/topic/dayprooxaprozin-tablets/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">b83dd8ed1db7eaebfdce1d5f540691e8</guid>
				<title>gregoryglass started the topic Paxil®(paroxetine) Orally Disintegrating Tablets in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/paxilparoxetine-orally-disintegrating-tablets/</link>
				<pubDate>Wed, 04 Oct 2023 13:20:35 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Paxil®(paroxetine) Orally Disintegrating Tablets  </b><br />
<b>Company: </b> Apotex<br />
<b>Petition Filer: </b> Lachman Consultants<br />
<b>Petition Number(s): </b> 2023P-4289<br />
<b>Date of First Petition: </b> October 3, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a orally disintegrating form of&hellip;<span class="activity-read-more" id="activity-read-more-1524"><a href="https://fdapetitions.com/forums/topic/paxilparoxetine-orally-disintegrating-tablets/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">7c898bf025aa0706d4d7eea8fcea39a8</guid>
				<title>gregoryglass started the topic Flexeril®(cyclobenzaprine) Orally Disintegrating Tablets in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/flexerilcyclobenzaprine-orally-disintegrating-tablets/</link>
				<pubDate>Wed, 04 Oct 2023 12:56:10 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Flexeril®(cyclobenzaprine) Orally Disintegrating Tablets</b><br />
<b>Company: </b> Janssen<br />
<b>Petition Filer: </b> Newcastle Bioscience<br />
<b>Petition Number(s): </b> 2023P-4284<br />
<b>Date of First Petition: </b> October 3, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a 5 mg and 10 mg orally disintegrating&hellip;<span class="activity-read-more" id="activity-read-more-1523"><a href="https://fdapetitions.com/forums/topic/flexerilcyclobenzaprine-orally-disintegrating-tablets/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">baf1e4df29a57e47ae9a24f42bfba9ae</guid>
				<title>gregoryglass started the topic Clistin®(carbinoxamine) Orally Disintegrating Tablets and Powder in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/clistincarbinoxamine-orally-disintegrating-tablets/</link>
				<pubDate>Wed, 04 Oct 2023 12:50:55 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Clistin®(carbinoxamine) Orally Disintegrating Tablets  </b><br />
<b>Company: </b> Ortho McNeil and<br />
<b>Petition Filer: </b> Pharmobedient<br />
<b>Petition Number(s): </b> 2023P-4283<br />
<b>Date of First Petition: </b> October 3, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a 4mg ODT form of&hellip;<span class="activity-read-more" id="activity-read-more-1522"><a href="https://fdapetitions.com/forums/topic/clistincarbinoxamine-orally-disintegrating-tablets/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">8b492b26d3efd8b954bede0f3691491d</guid>
				<title>gregoryglass started the topic Qmiiz ODT®(meloxicam) Orally Disintegrating Tablets in the forum Safety Petitions</title>
				<link>https://fdapetitions.com/forums/topic/qmiiz-odtmeloxicam-orally-disintegrating-tablets/</link>
				<pubDate>Wed, 04 Oct 2023 12:38:44 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Qmiiz ODT®(meloxicam) Orally Disintegrating Tablets </b><br />
<b>Company: </b> Tersera<br />
<b>Petition Filer: </b> Pharmobedient<br />
<b>Petition Number(s): </b> 2023P-4279<br />
<b>Date of Petition: </b> October 3, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Action Requested by Petitioner: </b> The petitioner would like to FDA to determine whether Qmiiz ODT®(meloxicam) Orally Disintegrating T&hellip;<span class="activity-read-more" id="activity-read-more-1521"><a href="https://fdapetitions.com/forums/topic/qmiiz-odtmeloxicam-orally-disintegrating-tablets/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">d2007700eb70fdbb959afa0776febaaa</guid>
				<title>gregoryglass started the topic Dolobid®(diflunisal) Orally Disintegrating Tablets in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/dolobiddiflunisal-odt/</link>
				<pubDate>Tue, 03 Oct 2023 16:49:17 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Dolobid®(diflunisal) Orally Disintegrating Tablets  </b><br />
<b>Company: </b> Merck, Teva<br />
<b>Petition Filer: </b> Pharmobedient, a consulting firm<br />
<b>Petition Number(s): </b> 2023P-4280<br />
<b>Date of First Petition: </b> October 2, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for an orally disintegrating tablet&hellip;<span class="activity-read-more" id="activity-read-more-1520"><a href="https://fdapetitions.com/forums/topic/dolobiddiflunisal-odt/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">7a6102f0e1b168e848db2f5280f30d33</guid>
				<title>gregoryglass started the topic Buprenex®(buprenorphine) Injection in the forum Safety Petitions Archives</title>
				<link>https://fdapetitions.com/forums/topic/buprenexbuprenorphine-injection/</link>
				<pubDate>Fri, 29 Sep 2023 11:28:54 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Buprenex®(buprenorphine) Injection </b><br />
<b>Company: </b> Indivior<br />
<b>Petition Filer: </b> Odin Pharmaceuticals<br />
<b>Petition Number(s): </b> 2023P-4223<br />
<b>Date of Petition: </b> September 28, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Action Requested by Petitioner: </b> The petitioner would like to FDA to determine whether   Buprenex®(buprenorphine) Injection (NDA 018401) was r&hellip;<span class="activity-read-more" id="activity-read-more-1519"><a href="https://fdapetitions.com/forums/topic/buprenexbuprenorphine-injection/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">cdf36ffc70562cbda395303ba0134294</guid>
				<title>gregoryglass started the topic Nucynta®(tapentadol) Oral Solution in the forum Safety Petitions</title>
				<link>https://fdapetitions.com/forums/topic/nucyntatapentadol-oral-solution/</link>
				<pubDate>Tue, 26 Sep 2023 11:00:34 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Nucynta®(tapentadol) Oral Solution </b><br />
<b>Company: </b> Collegium<br />
<b>Petition Filer: </b> Novitium<br />
<b>Petition Number(s): </b> 2023P-4065<br />
<b>Date of Petition: </b> September 20, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Action Requested by Petitioner: </b> The petitioner would like to FDA to determine whether Nucynta®(tapentadol) Oral Solution (NDA 203794) was removed from t&hellip;<span class="activity-read-more" id="activity-read-more-1518"><a href="https://fdapetitions.com/forums/topic/nucyntatapentadol-oral-solution/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">3a5ddc4aacfbea39831c8e4157493fc4</guid>
				<title>gregoryglass started the topic Zofran®(ondasentron) Orally Disintegrating Tablets in the forum Safety Petitions Archives</title>
				<link>https://fdapetitions.com/forums/topic/zofranondasentron-orally-disintegrating-tablets/</link>
				<pubDate>Tue, 29 Aug 2023 14:05:43 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Zofran®(ondasentron) Orally Disintegrating Tablets </b><br />
<b>Company: </b> Sandoz<br />
<b>Petition Filer: </b> Sun Pharmaceutical Industries<br />
<b>Petition Number(s): </b> 2023P-3682<br />
<b>Date of Petition: </b> August 28, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Action Requested by Petitioner: </b> The petitioner would like to FDA to determine whether Zofran®(ondasentron) Orally D&hellip;<span class="activity-read-more" id="activity-read-more-1517"><a href="https://fdapetitions.com/forums/topic/zofranondasentron-orally-disintegrating-tablets/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">d425f7813d29c450a9fde2a3732e906a</guid>
				<title>gregoryglass started the topic Synapse Labs Pvt Products in the forum Product Petitions</title>
				<link>https://fdapetitions.com/forums/topic/synapse-labs-pvt-products/</link>
				<pubDate>Sat, 26 Aug 2023 20:03:44 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Synapse Labs Pvt Products </b><br />
<b>Company: </b> Synapse Labs<br />
<b>Petition Filer: </b> The Flag<br />
<b>Petition Number(s): </b> 2023P-3634<br />
<b>Date of Petition: </b> August 25, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Issue and Implication:</b> Whether a foreign agency&#8217;s audit of a manufacturer determine TE codes in the US.</p>
<p><b>Action Requested by Petitioner: </b> The Petitioner is asking&hellip;<span class="activity-read-more" id="activity-read-more-1516"><a href="https://fdapetitions.com/forums/topic/synapse-labs-pvt-products/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">93dcbbc699d98a2abb61596707610816</guid>
				<title>gregoryglass started the topic Ozobax®(baclofen) Oral Solution in the forum Product Petitions</title>
				<link>https://fdapetitions.com/forums/topic/ozobaxbaclofen-oral-solution/</link>
				<pubDate>Tue, 22 Aug 2023 13:21:21 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Ozobax®(baclofen) Oral Solution  </b><br />
<b>Company: </b> Metacel<br />
<b>Petition Filer: </b> Metacel<br />
<b>Petition Number(s): </b> 2023P-3574<br />
<b>Date of Petition: </b> August 21, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Issue and Implication:</b> Whether an ANDA filer must conduct the same safety studies FDA required of the Petitioner/Drug Sponsor.</p>
<p><b>Action Requested by Petitioner: </b>&hellip;<span class="activity-read-more" id="activity-read-more-1515"><a href="https://fdapetitions.com/forums/topic/ozobaxbaclofen-oral-solution/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">9761c286ea3d80f42834be70c1a2daab</guid>
				<title>gregoryglass started the topic Sezaby®(phenobarbital sodium) Injection in the forum Product Petitions</title>
				<link>https://fdapetitions.com/forums/topic/sezabyphenobarbital-sodium-injection/</link>
				<pubDate>Wed, 26 Jul 2023 16:17:52 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Sezaby®(phenobarbital sodium) Injection  </b><br />
<b>Company: </b> Sun Pharma<br />
<b>Petition Filer: </b> Sun Pharma<br />
<b>Petition Number(s): </b> 2023P-3078<br />
<b>Date of Petition: </b> July 25, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Issue and Implication:</b> Whether FDA can remove an unapproved product that is marketed due to its excipients.</p>
<p><b>Action Requested by Petitioner: </b> The&hellip;<span class="activity-read-more" id="activity-read-more-1514"><a href="https://fdapetitions.com/forums/topic/sezabyphenobarbital-sodium-injection/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">83f3cd9d31199667c28fb5a2115b1867</guid>
				<title>gregoryglass started the topic Romidepsin Injection in the forum Safety Petitions</title>
				<link>https://fdapetitions.com/forums/topic/romidepsin-injection/</link>
				<pubDate>Thu, 13 Jul 2023 11:42:48 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Romidepsin Injection </b><br />
<b>Company: </b> Teva<br />
<b>Petition Filer: </b> E. Rust Consulting<br />
<b>Petition Number(s): </b> 2023P-2874<br />
<b>Date of Petition: </b> July 12, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Action Requested by Petitioner: </b> The petitioner would like to FDA to determine whether Romidepsin Injection 10mg/2mL and 27.5mg/5.5mL (5mg/mL) (NDA 205574) was removed&hellip;<span class="activity-read-more" id="activity-read-more-1513"><a href="https://fdapetitions.com/forums/topic/romidepsin-injection/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">50855741530f0c3d30d67c58e0ad82c7</guid>
				<title>gregoryglass started the topic Animal-derived Ingredients in the forum Issue Petitions</title>
				<link>https://fdapetitions.com/forums/topic/animal-derived-ingredients/</link>
				<pubDate>Thu, 13 Jul 2023 11:35:54 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Issue: Animal-derived Ingredients </b><br />
<b>Petition Filer: </b> VeganMed<br />
<b>Petition Number(s): </b> 2023P-2852<br />
<b>Date of Petition: </b> July 11,2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Issue and Implication:</b> Whether drugs are mis-labeled or adulterated if they contain ingredients derived from animals.</p>
<p><b>Action Requested by Petitioner: </b> The Petitioner is asking that FDA&hellip;<span class="activity-read-more" id="activity-read-more-1512"><a href="https://fdapetitions.com/forums/topic/animal-derived-ingredients/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">5e18f7faa74ae1e36d9ea240c2d36202</guid>
				<title>gregoryglass started the topic Ultram®(tramadol) Tablets in the forum Safety Petitions Archives</title>
				<link>https://fdapetitions.com/forums/topic/ultramtramadol-tablets/</link>
				<pubDate>Sun, 02 Jul 2023 11:55:37 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Ultram®(tramadol) Tablets </b><br />
<b>Company: </b> Janssen<br />
<b>Petition Filer: </b> Hymen Phelps, a law firm<br />
<b>Petition Number(s): </b> 2023P-2656<br />
<b>Date of Petition: </b> June 29, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Action Requested by Petitioner: </b> The petitioner would like to FDA to determine whether Ultram®(tramadol) Tablets 50mg (NDA 020281) was removed from the m&hellip;<span class="activity-read-more" id="activity-read-more-1511"><a href="https://fdapetitions.com/forums/topic/ultramtramadol-tablets/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">885a20f9d11ebab074d5e44956d66bed</guid>
				<title>gregoryglass started the topic Foradil®(formoterol) Inhalation Powder in the forum Safety Petitions Archives</title>
				<link>https://fdapetitions.com/forums/topic/foradilformoterol-inhalation-powder/</link>
				<pubDate>Fri, 23 Jun 2023 18:49:36 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Foradil®(formoterol) Inhalation Powder </b><br />
<b>Company: </b> Novartis<br />
<b>Petition Filer: </b> K&amp;L Gates, a law firm<br />
<b>Petition Number(s): </b> 2023P-2536<br />
<b>Date of Petition: </b> June 21, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Action Requested by Petitioner: </b> The petitioner would like to FDA to determine whether Foradil®(formoterol) Inhalation Powder (NDA 020831) was r&hellip;<span class="activity-read-more" id="activity-read-more-1510"><a href="https://fdapetitions.com/forums/topic/foradilformoterol-inhalation-powder/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">849bda27e35c67f7e40ddc64c1c80f2d</guid>
				<title>gregoryglass started the topic Neffy®(epinephrine) Intranasal in the forum Product Petitions Archives</title>
				<link>https://fdapetitions.com/forums/topic/neffyepinephrine-intranasal/</link>
				<pubDate>Tue, 13 Jun 2023 17:52:08 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Neffy®(epinephrine) Intranasal  </b><br />
<b>Company: </b> ARS Pharmaceuticals<br />
<b>Petition Filer: </b> Viatris<br />
<b>Petition Number(s): </b> 2023P-2392<br />
<b>Date of Petition: </b> June 12, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Issue and Implication:</b> Whether FDA can approve a 505(b)(2) NDA that uses a different route of administration than the reference list drugs.</p>
<p><b>Action&hellip;</b><span class="activity-read-more" id="activity-read-more-1509"><a href="https://fdapetitions.com/forums/topic/neffyepinephrine-intranasal/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">0565a072da03ce3c664166b3e7931cda</guid>
				<title>gregoryglass started the topic K-Tab®(potassium) Extended-release Tablets in the forum Safety Petitions Archives</title>
				<link>https://fdapetitions.com/forums/topic/k-tabpotassium-extended-release-tablets/</link>
				<pubDate>Sat, 10 Jun 2023 19:18:15 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: K-Tab®(potassium) Extended-release Tablets </b><br />
<b>Company: </b> Abbvie<br />
<b>Petition Filer: </b> Granules<br />
<b>Petition Number(s): </b> 2023P-2339<br />
<b>Date of Petition: </b> June 8, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Action Requested by Petitioner: </b> The petitioner would like to FDA to determine whether K-Tab®(potassium) Extended-release Tablets (NDA 018279) was removed f&hellip;<span class="activity-read-more" id="activity-read-more-1508"><a href="https://fdapetitions.com/forums/topic/k-tabpotassium-extended-release-tablets/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">837d32319f63c3e824fcb515d01eedd4</guid>
				<title>gregoryglass started the topic Mexitil®(mexiletine) Capsules in the forum Suitability Petitions</title>
				<link>https://fdapetitions.com/forums/topic/mexitilmexiletine-capsules/</link>
				<pubDate>Sat, 27 May 2023 10:34:14 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Mexitil®(mexiletine) Capsules  </b><br />
<b>Company: </b> Boehringer Ingelheim<br />
<b>Petition Filer: </b> Rising Pharma<br />
<b>Petition Number(s): </b> 2023P-2157<br />
<b>Date of First Petition: </b> May 26, 2023<br />
<b>Responding Petitions: </b> None</p>
<p><b>Action Requested of Petition: </b> Petitioner would like to file an ANDA for a 300 mg strength of mexiletine capsules. Using&hellip;<span class="activity-read-more" id="activity-read-more-1507"><a href="https://fdapetitions.com/forums/topic/mexitilmexiletine-capsules/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
					<item>
				<guid isPermaLink="false">67db10f3d5b22812fbcb9dea5f594b09</guid>
				<title>gregoryglass started the topic Cogentin®(benztropine) Injection in the forum Safety Petitions Archives</title>
				<link>https://fdapetitions.com/forums/topic/cogentinbenztropine-injection/</link>
				<pubDate>Wed, 24 May 2023 12:37:25 +0000</pubDate>

									<content:encoded><![CDATA[<p><b>Product: Cogentin®(benztropine) Injection </b><br />
<b>Company: </b> Akorn<br />
<b>Petition Filer: </b> Nexus<br />
<b>Petition Number(s): </b> 2023P-2055<br />
<b>Date of Petition: </b> May 222, 2023<br />
<b>Responding Petitions: </b> </p>
<p><b>Action Requested by Petitioner: </b> The petitioner would like to FDA to determine whether Cogentin®(benztropine) Injection (NDA 012015) was removed from the market for r&hellip;<span class="activity-read-more" id="activity-read-more-1506"><a href="https://fdapetitions.com/forums/topic/cogentinbenztropine-injection/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
		
	</channel>
</rss>